The SKS Technologies Group Ltd (ASX: SKS) share price is in focus today after the company reported a record-breaking FY26, with sales revenue jumping 33.0% to $347.93 million and after-tax profit almost doubling to $27.11 million.

What did SKS Technologies report?

• Sales revenue: up 33.0% to $347.93 million (FY25: $261.66 million)
• Profit before tax: up 89.3% to $39.35 million (FY25: $20.79 million)
• Net profit after tax: up 93.2% to $27.11 million
• EBITDA: up 80.8% to $42.43 million
• Earnings per share: up 91.2% to 23.45 cents
• Full year dividend: 10.0 cents per share (up 66.7%)

What else do investors need to know?

SKS made significant strategic moves over FY26, including the acquisition and integration of Delta Elcom, boosting its presence in New South Wales and accelerating its push into the data centre market. A highlight for the year was securing a $210 million contract for a hyperscale data centre in Melbourne, which set a record for the group and showcased its growing capacity.

The company’s work on hand surged to $312 million at 30 June 2026, up from $200 million a year prior, providing a strong platform for future revenue. Importantly, SKS maintained its excellent safety record with zero lost time injuries, even as its workforce and hours worked both climbed.

What did SKS Technologies management say?

Chief Executive Officer Matthew Jinks said:

For the last several years, we have achieved quantum leaps in our financial, operational and people metrics that defy the norm and despite the challenges of the effect of compounding, take the business to the next level year on year.

What’s next for SKS Technologies?

SKS Technologies is targeting further growth, with the board forecasting FY27 sales revenue in the vicinity of $500 million and profit before tax of $60 million. Its expanded bank facilities and cash position provide flexibility and backing for continued investment and expansion, particularly in data centre infrastructure.

Ongoing improvements in technology, operational systems, and training are in place to ensure sustained productivity and the ability to meet strong demand in targeted markets, including major government and private sector projects.

SKS Technologies Group share price snapshot

Over the past 12 months, SKS Technologies shares have risen 260%, outperforming the All Ordinaries Index (ASX: XAO), which is flat over the same period.

View Original Announcement

The post SKS Technologies reports record FY26 earnings appeared first on The Motley Fool Australia.

More reading

• Up 250%! Broker tips this dividend paying ASX All Ords tech stock for more outsized gains
• SKS Technologies smashes profit guidance in earnings update
• Buy, hold, sell: SKS Technologies, Yancoal, Wesfarmers shares

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sks Technologies Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Pro Medicus Ltd (ASX: PME) share price is in focus today as the company announced full-year revenue of $261.7 million, up 22.9%, with underlying NPAT rising 24.1% to $144.7 million. The company remains debt-free and has lifted its fully-franked total dividend by 25.5% to 69 cents per share.

What did Pro Medicus report?

• Revenue: $261.7 million, up 22.9% year-on-year
• Underlying EBIT: $196.1 million, up 24.4%
• Reported NPAT: $265.3 million, up 130.3%
• Underlying NPAT: $144.7 million, up 24.1%
• Cash and financial assets: $252.3 million, up 19.7%
• Final dividend: 37 cents per share, total full-year dividend 69 cents, up 25.5%

What else do investors need to know?

Pro Medicus signed 10 new contracts during the year, totalling at least $407 million in value, including a major 10-year deal with UC Health Colorado. The company also renewed six key contracts, worth $141 million, all on five-year terms with increased transaction fees.

On a constant currency basis, revenue, EBIT, and NPAT each saw gains above 28%. The company’s pipeline remains strong, supported by new product launches in digital pathology and AI-optimised reporting as well as a nearly complete Trinity implementation.

What did Pro Medicus Limited management say?

Dr Sam Hupert, Chief Executive Officer, said:

We were aiming for 30% increases in EBIT and NPAT, and we exceeded both on a constant currency basis. Importantly, we have proven that with one platform and one business model we can address virtually every opportunity in diagnostic imaging, providing us with the largest total addressable market. Progress made in the cardiology market represents another important string to our bow. We see this trend continuing.

What’s next for Pro Medicus?

Looking ahead, Pro Medicus says it expects to benefit from its newly signed contracts and recent implementations, particularly as the Trinity rollout is now largely complete. Management highlights a strong pipeline with a growing number of inbound requests from major US healthcare institutions.

The company is aiming to further expand its presence in both diagnostic imaging and cardiology, leveraging its one-platform approach and ongoing product innovation.

Pro Medicus share price snapshot

Over the past year, the Pro Medicus share price has underperformed the S&P/ASX 200 index (ASX: PME) with a decline of around 45%.

View Original Announcement

The post Pro Medicus FY26: Strong earnings growth and higher dividend appeared first on The Motley Fool Australia.

More reading

• Reporting season half-time report: 5 lessons from August so far
• 5 things to watch on the ASX 200 on Tuesday
• How to build a strong ASX retirement portfolio with 10 shares
• 3 ASX growth shares I want to buy and hold forever
• Why I’d buy and hold Pro Medicus and DroneShield shares

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Sims Ltd (ASX: SGM) share price is in focus after the company posted a 6.9% rise in full-year group revenue to $8,007.5 million, and underlying EBIT up 167.6% to $468.0 million.

What did Sims Ltd report?

• Group sales revenue increased 6.9% to $8,007.5 million
• Underlying EBITDA jumped 69.3% to $727.8 million
• Underlying EBIT surged 167.6% to $468.0 million
• Underlying NPAT rose to $289.1 million (up from $83.1 million)
• Return on Invested Capital (ROIC) improved by 7.2 percentage points to 11.7%
• Final fully franked dividend of 20.0 cents per share, bringing the full-year total to 34.0 cents

What else do investors need to know?

Sims’ Sims Lifecycle Services (SLS) division delivered standout growth, with sales revenue up 77.4% to $757 million, and underlying EBIT climbing 429.8% to $172.7 million, driven by strong demand for recovered memory components in the AI infrastructure sector. Repurposed units almost doubled to 16.8 million, reflecting deepening relationships with hyperscale data centre customers.

The North American and SA Recycling segments benefited from favourable non-ferrous prices and domestic US steel demand, offsetting ongoing challenges in the Australian and New Zealand metals business due to soft steel markets and limited tariff protection.

What’s next for Sims Ltd?

Looking ahead, Sims expects supportive market conditions for non-ferrous metals and AI-related asset recovery to continue into FY27. While the timing of data centre decommissioning remains variable, the company expects SLS to contribute first-half underlying EBIT between $75 million and $90 million.

The group also sees ongoing US tariffs and new electric arc furnace capacity supporting demand for ferrous scrap in North America. In Australia and New Zealand, domestic demand could strengthen over the medium term as new steel production capacity comes online. Sims remains focused on recovery optimisation, operational excellence, and disciplined growth through targeted investments and bolt-on acquisitions.

Sims share price snapshot

The Sims share price has been a very strong performer over the past 12 months, outperforming the S&P/ASX 200 index (ASX: XJO) with a gain of around 50%.

View Original Announcement

The post Sims delivers strong FY26 earnings growth as AI demand fuels SLS division appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.